Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Elypta, a Sweden-based cancer diagnostics spinout of Chalmers University of Technology, has obtained SEK64.8m ($5.2m) in a round featuring the university’s investment and incubator arm, Chalmers Ventures, as well as Swedish government-owned investment arm Industrifonden, social entrepreneurship incubator Norrsken Foundation, equity crowdfunding platform Sciety and undisclosed business angels. The spinout is working on AI-driven cancer diagnostics based on biomarkers in urine samples, and will use the funding to distribute its first product – for kidney cancer – to urologists and…
